Ambu A/S
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMBBY research report →
Companywww.ambu.com
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
- CEO
- Britt Meelby Jensen
- IPO
- 2021
- Employees
- 5,000
- HQ
- Ballerup, DK
Price Chart
Valuation
- Market Cap
- $2.70B
- P/E
- 37.08
- P/S
- 2.89
- P/B
- 2.90
- EV/EBITDA
- 16.89
- Div Yield
- 0.62%
Profitability
- Gross Margin
- 55.82%
- Op Margin
- 10.71%
- Net Margin
- 7.81%
- ROE
- 7.92%
- ROIC
- 7.56%
Growth & Income
- Revenue
- $5.69B · 5.47%
- Net Income
- $573.61M · 144.09%
- EPS
- $2.15 · 144.32%
- Op Income
- $738.45M
- FCF YoY
- 21.15%
Performance & Tape
- 52W High
- $16.78
- 52W Low
- $9.57
- 50D MA
- $10.45
- 200D MA
- $13.27
- Beta
- 1.26
- Avg Volume
- 204
Get TickerSpark's AI analysis on AMBBY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AMBBY Coverage
We haven't published any research on AMBBY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AMBBY Report →